BioChain Institute Overview
- Year Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
41
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
- Investments
-
2
BioChain Institute General Information
Description
Developer of integrated tools for biomedical research intended to obtain disease diagnosis and drug discovery. The company engages in the development of processed bio-sample products, which can be used in the field of genomics, proteomics, drug discovery, and clinical diagnosis, thereby accelerating innovation for life sciences.
Contact Information
Website
www.biochain.com(Operating Subsidiary)
Corporate Office
- 39600 Eureka Drive
- Newark, CA 94560
- United States
Corporate Office
- 39600 Eureka Drive
- Newark, CA 94560
- United States
BioChain Institute Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioChain Institute Comparisons
Industry
Financing
Details
BioChain Institute Competitors (13)
One of BioChain Institute’s 13 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
| Source Bioscience | Corporation | Nottingham, United Kingdom | ||||
| WuXi AppTec | Formerly PE-Backed | Shanghai, China | ||||
| STEMCELL Technologies | Private Debt Financed | Vancouver, Canada | ||||
| BioGenex Laboratories | Corporation | Fremont, CA |
BioChain Institute Patents
BioChain Institute Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019226734-A1 | Target enrichment and sequencing of modified nucleic acid for human cancer detection | Inactive | 22-May-2018 | ||
| US-20190390282-A1 | Target enrichment and sequencing of modified nucleic acids for human cancer detection | Inactive | 22-May-2018 | ||
| WO-2018151709-A1 | Automated isolation and chemical reaction(s) of nucleic acids | Inactive | 14-Feb-2017 | ||
| US-11078477-B2 | Automated isolation and chemical reaction(s) of nucleic acids | Active | 17-Oct-2014 | ||
| US-20160108459-A1 | Automated isolation and chemical reaction(s) of nucleic acids | Inactive | 17-Oct-2014 | C12Q1/6806 |
BioChain Institute Signals
BioChain Institute Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioChain Institute Investments (2)
BioChain Institute’s most recent deal was a PIPE with Epigenomics for . The deal was made on 16-Nov-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Epigenomics | 16-Nov-2016 | PIPE | Diagnostic Equipment | ||
| Epigenomics | 16-Oct-2014 | PIPE | Diagnostic Equipment |
BioChain Institute Exits (2)
BioChain Institute’s most recent exit was on 16-Nov-2016 from Epigenomics. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Epigenomics | 16-Nov-2016 | Completed |
|
||
| Epigenomics | 16-Oct-2014 | PIPE | Completed |
BioChain Institute FAQs
-
When was BioChain Institute founded?
BioChain Institute was founded in 1994.
-
Where is BioChain Institute headquartered?
BioChain Institute is headquartered in Newark, CA.
-
What is the size of BioChain Institute?
BioChain Institute has 41 total employees.
-
What industry is BioChain Institute in?
BioChain Institute’s primary industry is Diagnostic Equipment.
-
Is BioChain Institute a private or public company?
BioChain Institute is a Private company.
-
What is BioChain Institute’s current revenue?
The current revenue for BioChain Institute is .
-
Who are BioChain Institute’s investors?
3E Bioventures Capital, Kevron Holdings, SummitView Capital, and U.S. Department of Health and Human Services have invested in BioChain Institute.
-
Who are BioChain Institute’s competitors?
Bio-Rad Laboratories, Source Bioscience, WuXi AppTec, STEMCELL Technologies, and BioGenex Laboratories are some of the 13 competitors of BioChain Institute.
-
When was BioChain Institute acquired?
BioChain Institute was acquired on 01-May-2025.
-
Who acquired BioChain Institute?
BioChain Institute was acquired by CellBio Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process